{{text}}
| Global rank | 869 399 |
|---|---|
| Daily visitors | - |
| Daily pageviews | - |
| Pageviews per user | 0 |
| Rating | |
|---|---|
| Latest check |
Pharmatechoutlook.com is tracked by us since November, 2015. Over the time it has been ranked as high as 164 099 in the world, while most of its traffic comes from USA, where it reached as high as 100 167 position. Vaccine-discovery-and-development-europe.pharmatechoutlook.com receives less than 3.86% of its total traffic. It was hosted by Amazon Technologies Inc.. While GODADDY.COM LLC was its first registrar, now it is moved to GoDaddy.com LLC.
Vaccine-discovery-and-development-europe.pharmatechoutlook has the lowest Google pagerank and bad results in terms of Yandex topical citation index. We found that Vaccine-discovery-and-development-europe.pharmatechoutlook.com is poorly ‘socialized’ in respect to any social network. According to Google safe browsing analytics, Vaccine-discovery-and-development-europe.pharmatechoutlook.com is quite a safe domain with no visitor reviews.
Pharmatechoutlook.com gets 79.04% of its traffic from USA where it is ranked #125719.
Top Countries
|
|
79.0% |
|
|
2.9% |
|
|
2.5% |
|
|
1.6% |
|
|
1.4% |
Top Ranks
|
|
86 711 |
|
|
125 719 |
|
|
306 131 |
|
|
363 733 |
|
|
365 870 |
It seems that the number of visitors and pageviews on this site is too low to be displayed, sorry.
Pharmacovigilance.pharmatechoutlook.com is the most popular subdomain of Pharmatechoutlook.com with 5.05% of its total traffic.
Top Subdomains
pharmacovigilance.pharmatechoutlook.com
5.05%
enterprise-software.pharmatechoutlook.com
4.88%
4.33%
biotech-startup.pharmatechoutlook.com
3.86%
other
43.89%
This Subdomain
Vaccine-discovery-and-development-europe.pharmatechoutlook.com is not yet effective in its SEO tactics: it has Google PR 0. It may also be penalized or lacking valuable inbound links.
Ranks
0
Google PR
-
Yandex CY
| Homepage Top Backlinks | PR |
|---|---|
| No data |
Metadata Updates
Get more Vaccine-discovery-and-development-europe.pharmatechoutlook.com metadata updates
{{text}}
| Top Keywords | % of search traffic |
|---|---|
| No data |
Vaccine-discovery-and-development-europe.pharmatechoutlook.com domain is owned by Registration Private Domains By Proxy, LLC and its registration expires in 7 months.
Registration Private Domains By Proxy, LLC
Owner since April 13, 2022
7 months left
Expires on January 08, 2025
10 years old
Created on January 08, 2014
4 months ago
Changed at January 09, 2024
In Other TLDs
No data
It seems Vaccine-discovery-and-development-europe.pharmatechoutlook.com has no mentions in social networks.
Vaccine-discovery-and-development-europe.pharmatechoutlook.com is hosted by Amazon Technologies Inc.
Amazon Technologies Inc.
52.33.124.163
IP address
Server technologies
Apache HTTP Server
Backend server
DNS Records
Host
vaccine-discovery-and-development-europe.pharmatechoutlook.com
Value
52.33.124.163
ttl
300
Nameservers
No data
Safety status of Vaccine-discovery-and-development-europe.pharmatechoutlook.com is described as follows: Google Safe Browsing reports its status as safe.
MyWOT
| Overall reputation | Unknown |
|---|---|
| Trustworthiness | Unknown |
| Privacy | Unknown |
| Child safety | Unknown |
Google Safe Browsing
| Website status | Safe |
|---|---|
| Status | ok |
User reviews
| Reputation | Unknown |
|---|
0
Positive0
NegativeRecently analyzed sites